Gunnstein Norheim

Author PubWeight™ 9.33^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes.	J Clin Microbiol	2005	1.82
2	The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.	Vaccine	2005	1.17
3	Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient.	Genome Biol	2014	1.17
4	Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.	Vaccine	2013	0.98
5	Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.	Proc Natl Acad Sci U S A	2013	0.91
6	Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.	Vaccine	2012	0.88
7	Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.	Clin Vaccine Immunol	2013	0.78
8	Genetic and structural characterization of L11 lipooligosaccharide from Neisseria meningitidis serogroup A strains.	J Biol Chem	2010	0.77
9	Surveillance of Bacterial Meningitis, Ethiopia, 2012-2013.	Emerg Infect Dis	2016	0.76